These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6130440)

  • 1. In vivo cellular responses to electrophoretically applied dynorphin in the rat hippocampus.
    Henriksen SJ; Chouvet G; Bloom FE
    Life Sci; 1982 Oct 18-25; 31(16-17):1785-8. PubMed ID: 6130440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.
    Moises HC; Walker JM
    Eur J Pharmacol; 1985 Jan; 108(1):85-98. PubMed ID: 2858395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin-A alters the excitability of pyramidal neurons of the rat hippocampus in vitro.
    Gruol DL; Chavkin C; Valentino RJ; Siggins GR
    Life Sci; 1983; 33 Suppl 1():533-6. PubMed ID: 6141499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid peptides and epileptogenesis in the limbic system: cellular mechanisms.
    Siggins GR; Henriksen SJ; Chavkin C; Gruol D
    Adv Neurol; 1986; 44():501-12. PubMed ID: 2939697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate antagonists do not alter neuronal responses to stimulation of opioid-containing pathways in rat hippocampus.
    Chavkin C; Bloom FE
    Neuropeptides; 1986 Jan; 7(1):19-22. PubMed ID: 2869440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An iontophoretic survey of opioid peptide actions in the rat limbic system: in search of opiate epileptogenic mechanisms.
    French ED; Siggins GR
    Regul Pept; 1980 Oct; 1(2):127-46. PubMed ID: 6265978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hippocampal opioidergic system: a comparative immunocytochemical study in four rodents.
    Rácz B; Füzesi M; Halasy K
    Neurobiology (Bp); 1998; 6(4):429-41. PubMed ID: 10220778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dynorphin A (1-17), dynorphin A (1-13) and D-ala2-D-leu5-enkephalin on the excitability of pyramidal cells in CA1 and CA2 of the rat hippocampus in vitro.
    Vidal C; Maier R; Zieglgänsberger W
    Neuropeptides; 1984 Dec; 5(1-3):237-40. PubMed ID: 6152322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster.
    McLean S; Rothman RB; Jacobson AE; Rice KC; Herkenham M
    J Comp Neurol; 1987 Jan; 255(4):497-510. PubMed ID: 2880880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of kyotorphin on the reactivity of hippocampal neurons].
    Chepkova AN; Zotov VM
    Biull Eksp Biol Med; 1986 May; 101(5):578-81. PubMed ID: 3708143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
    Madamba SG; Schweitzer P; Siggins GR
    J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evidence for different opioid systems in the rat superior cervical ganglion as revealed by imipramine treatment and receptor blockade.
    Folan JC; Heym C
    J Chem Neuroanat; 1989; 2(2):107-18. PubMed ID: 2574980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for dynorphin-A as a neurotransmitter in rat hippocampus.
    Chavkin C; Bakhit C; Bloom FE
    Life Sci; 1983; 33 Suppl 1():13-6. PubMed ID: 6141483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect.
    Sandin J; Nylander I; Georgieva J; Schött PA; Ogren SO; Terenius L
    Neuroscience; 1998 Jul; 85(2):375-82. PubMed ID: 9622237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity.
    McGinty JF; Henriksen SJ; Goldstein A; Terenius L; Bloom FE
    Proc Natl Acad Sci U S A; 1983 Jan; 80(2):589-93. PubMed ID: 6132379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region.
    Chavkin C; Henriksen SJ; Siggins GR; Bloom FE
    Brain Res; 1985 Apr; 331(2):366-70. PubMed ID: 2859095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus.
    Chavkin C; Bakhit C; Weber E; Bloom FE
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7669-73. PubMed ID: 6143317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects of mu-, delta- and kappa-opiate agonists and, in particular, dynorphin at the spinal level.
    Przewłocki R; Stala L; Greczek M; Shearman GT; Przewłocka B; Herz A
    Life Sci; 1983; 33 Suppl 1():649-52. PubMed ID: 6141505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting interactions of the locus coeruleus as compared to the ventral noradrenergic bundle with CNS and pituitary pools of vasopressin, dynorphin and related opioid peptides in the rat.
    Millan MJ; Millan MH; Członkowski A; Herz A
    Brain Res; 1984 Apr; 298(2):243-52. PubMed ID: 6144361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.